AtriCure® is committed to aiding physicians in adapting to evolving products and techniques. Our physician training programs are designed with the guidance of an Education Steering committee comprised of key opinion leaders to help individuals at all experience levels learn more about the surgical treatment of Atrial Fibrillation. We are dedicated to helping you focus on deepening your expertise and improving patient care.
Maze IV Training Program
First and ONLY training course on the concomitant surgical treatment for persistent and longstanding persistent Atrial Fibrillation patients:
Trained Maze IV Physician Benefits
On December 14, 2011, AtriCure received FDA approval for the Isolator® Synergy™ Ablation System, which is the first and only surgical device approved for the surgical treatment of Atrial Fibrillation and the only device either surgical or catheter, approved to treat persistent and long-standing persistent classifications of Afib.